Patent · US Expired

Streptomyces mediterranei mutant capable of production of rifamycin B

US4267274A · kind A · utility

5Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 1974
Grant dateMay 12, 1981
Priority date—
Expiry dateJun 13, 1994

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/886
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A biologically pure culture of Streptomyces mediterranei mutant strain 18, ATCC.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.